Global $5.4 Billion Drug Discovery Outsourcing Market to 2028

DUBLIN, Feb. 25, 2021 /PRNewswire/ -- The "Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report by Workflow (Lead Identification & Candidate Optimization, Others), by Therapeutics Area (Oncology, Respiratory System), by Drug Type, and Segment Forecasts, 2021-2028" report has been added to's offering.

The global drug discovery outsourcing market size is expected to reach USD 5.4 billion by 2028 registering a CAGR of 7.4% over the forecast period.

Drug discovery is a costly and lengthy process. This has forced pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Thus, factors such as high R&D costs, patent expiration of best-selling drugs, and the need to speed up the drug discovery process, are expected to boost the demand for outsourcing of drug discovery in the coming years.

Rising cases of chronic diseases have compelled companies to develop better medicines. Some of the key therapeutic areas where companies are actively involved in outsourcing include oncology, cardiovascular, and anti-infectives. In November 2020, AstraZeneca collaborated with 9 of the foremost oncology medical centers to expedite research in some of the hardest-to-treat cancers.

The company will be funding clinical and non-clinical research proposals from members within this network. The COVID-19 pandemic has brought pharmaceutical companies in limelight. It is demonstrating the value of drug discovery and development.

Several companies are proactively involved in developing an effective vaccine to treat the disease. Pfizer Inc. and BioNTech SE received the first approval for the vaccine following a worldwide Phase 3 trial of a potential strain to combat the virus. As for clinical trials, many of them are halted, while some are functional by adopting remote monitoring technologies.

Thus, the pandemic has brought the pharmaceutical industry to center-stage, with drug discovery outsourcing becoming a key aspect to develop effective treatments against the virus. This is expected to boost the market revenue for the next 2 years i.e. a short-term boom, after which it shall regain its original growth curve.

Drug Discovery Outsourcing Market Report Highlights

    --  Lead identification & candidate optimization was the dominant workflow
        segment of the global market in 2020.
    --  The segment will retain its leading position throughout the forecast
        period as lead identification & candidate optimization is one of the
        critical processes in drug discovery.
    --  The oncology therapeutics area segment is projected to register the
        fastest CAGR from 2021 to 2028.
    --  The small molecules drug type segment led the market in 2020 and is also
        projected to record the fastest growth rate during the forecast period.
        This, however, may change in the short term with a higher emphasis on
    --  In terms of revenue share, North America is estimated to be the leading
        regional market during the forecast period.
    --  However, Asia Pacific is projected to be the fastest-growing regional
        market from 2021 to 2028 owing to government initiatives to forge
        alliances with the U.S. pharmaceutical companies.

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Drug Discovery Outsourcing Market Variables, Trends & Scope
3.1. Penetration & Growth Prospect Mapping
3.2. Industry Value Chain Analysis
3.2.1. Reimbursement framework
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.3.3. Industry challenges
3.4. Drug Discovery Outsourcing Market Analysis Tools
3.4.1. Industry Analysis - Porter's
3.4.2. PESTEL Analysis
3.4.3. Major Deals & Strategic Alliances Analysis
3.4.4. Market Entry Strategies

Chapter 4. Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Definitions and Scope
4.3. Drug Discovery Outsourcing Market Share, 2020 & 2028
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.4.1. Target Identification & Screening
4.4.2. Target Validation & Functional Informatics
4.4.3. Lead Identification & Candidate Optimization
4.4.4. Preclinical Development
4.4.5. Other Associated Workflow

Chapter 5. Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Definitions and Scope
5.3. Drug Discovery Outsourcing Market Share, 2020 & 2028
5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.4.1. Respiratory System
5.4.2. Pain & Anesthesia
5.4.3. Oncology
5.4.4. Ophthalmology
5.4.5. Hematology
5.4.6. Cardiovascular
5.4.7. Endocrine
5.4.8. Gastrointestinal
5.4.9. Immunomodulation
5.4.10. Anti-Infective
5.4.11. Central Nervous System
5.4.12. Dermatology
5.4.13. Genitourinary System

Chapter 6. Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Definitions and Scope
6.3. Drug Discovery Outsourcing Market Share, 2020 & 2028
6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.4.1. Small Molecules
6.4.2. Large Molecules (Biopharmaceuticals)

Chapter 7. Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2020 & 2028
7.3. Regional Market Share, 2020

Chapter 8. Competitive Landscape
8.1. Company overview
8.2. Financial performance
8.3. Product benchmarking
8.4. Strategic initiatives

    --  Albany Molecular Research Inc.
    --  EVOTEC
    --  Laboratory Corporation of America Holdings
    --  GenScript
    --  PPD Inc
    --  Charles River
    --  WuXi AppTec
    --  Merck & Co., Inc.
    --  Thermo Fisher Scientific Inc.
    --  Dalton Pharma Services
    --  Oncodesign
    --  Jubilant Biosys
    --  DiscoverX Corporation
    --  QIAGEN

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets